Citation Impact
Citing Papers
Lobeline and Nicotine Evoke [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine: Differential Inhibition of Synaptosomal and Vesicular [3H]Dopamine Uptake
1997
Gout: On the brink of novel therapeutic options for an ancient disease
2004
Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal–prefrontal cortex long-term potentiation
1999
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
1997
DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task
2000 StandoutNobel
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Getting Formal with Dopamine and Reward
2002 Standout
Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake
1990
Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics
1991
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics
2006
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
2006
Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
1995
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
1996 Standout
Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model
1990
The Continuing Unethical Use of Placebo Controls
1994
Cannabinoid Transmission and Reward-Related Events
1998
Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide
1988
Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron
1992
The adolescent brain and age-related behavioral manifestations
2000 Standout
What Makes Clinical Research Ethical?
2000 Standout
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Neurochemistry and neuropharmacology of emesis — the role of serotonin
2000
Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation
1987
Gout
2009 Standout
Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: Possible autoreceptor effect
1993
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Ondansetron versus Chlorpromazine for Preventing Emesis in Bone Marrow Transplant Recipients: a Double-Blind Randomized Study
1993
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy
1991
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study
1993
Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy
1992
Hierarchical models of object recognition in cortex
1999 Standout
Catecholamine release and uptake in the mouse prefrontal cortex
2001
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
1996
Dynamic Observation of Dopamine Autoreceptor Effects in Rat Striatal Slices
1992
Cellular processing of platinum anticancer drugs
2005 Standout
Stress‐Related Activation of Cerebral Dopaminergic Systemsa
1988
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
β Phorbol Ester- and Diacylglycerol-Induced Augmentation of Transmitter Release Is Mediated by Munc13s and Not by PKCs
2002 StandoutNobel
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors
1987
The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity.
2002 Standout
Chronic cocaine treatment does not alter rat striatal D2 autoreceptor sensitivity to pergolide
1991
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
The Mechanism of Action of Novel Antipsychotic Drugs
1991
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
1992
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
1991 Standout
Persistent augmented dopamine release after acute cocaine requires dopamine receptor activation
1989
Protein kinase C: a physiological mediator of enhanced transmitter output
1998
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors
1993
Methodology of antiemetic trials: A review
1991
Control of Chemotherapy-Induced Emesis
1993
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
1991
Dopamine uptake: A review of progress in the last decade
1990
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task
2000
Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens.
1990
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
2004
Under the curve: Critical issues for elucidating D1 receptor function in working memory
2005
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Visceral perception in irritable bowel syndrome
1995
Parkinson's Disease
2003 Standout
One injection of cocaine produces a long-lasting increase in [3H]-dopamine release
1987
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin
1996
Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum
1980
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis
2010
Modulating the Anticancer Activity of Ruthenium(II)–Arene Complexes
2015
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
1991 StandoutScienceNobel
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989 StandoutNobel
Dopamine, the prefrontal cortex and schizophrenia
1997
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion
2001 Standout
Current status of trans-platinum compounds in cancer therapy
2001
Additions to Metal-Activated Organonitriles
2002 Standout
Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study
1994
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Conjugated Dopamine in Superfusates of Slices of Rat Striatum
1982
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors
1991
Autoreceptor-mediated changes in dopaminergic terminal excitability: Effects of increases in impulse flow
1984
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis
1984
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
2006
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm
1987 StandoutNobel
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter
1998
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Management of High Blood Pressure in Blacks
2010
Synthesis and Characterization of AP5346, a Novel Polymer-Linked Diaminocyclohexyl Platinum Chemotherapeutic Agent
2006
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Autoreceptor-mediated changes in dopaminergic terminal excitability: Effects of striatal drug infusions
1984
On Serotonin and Migraine: A Clinical and Pharmacological Review
1993
Different Effects on Fast Exocytosis Induced by Synaptotagmin 1 and 2 Isoforms and Abundance But Not by Phosphorylation
2006 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
Turnover of Dopamine and Dopamine Metabolites in Rat Brain: Comparison Between Striatum and Substantia Nigra
1987 StandoutNobel
Nonlinear neural networks: Principles, mechanisms, and architectures
1988 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
1997
Peptide Targeting of Platinum Anti-Cancer Drugs
2009
Works of Irene Hoffmann being referenced
Nitric oxide and salt sensitivity
2000
Is the Release of Dopamine from Medial Prefrontal Cortex Modulated by Presynaptic Receptors? Comparison with Nigrostriatal and Mesolimbic Terminals
1990
Clustering of silent cardiovascular risk factors in apparently healthy Hispanics
2002
Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs
1992
Ondansetron and Metformin-Induced Gastrointestinal Side Effects
2003
Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics
2004
Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slices
1991
Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting
1990
Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
1980
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
1986
Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
1979
Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
1988
Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
1994
Rate and Duration of Stimulation Determine Presynaptic Effects of Haloperidol on Dopaminergic Neurons
1982
Frequency‐Dependent Release of Acetylcholine and Dopamine From Rabbit Striatum: Its Modulation by Dopaminergic Receptors
1983
Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum.
1983
Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors.
1982
Dopamine Autoreceptors Modulate Dopamine Release from the Prefrontal Cortex
1986
Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
1983